Maze Therapeutics Inc
Maze Therapeutics Inc (MAZE) Wheel Strategy
MAZE wheel strategy scan found 2 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 39.3%.
Read more
Running a MAZE wheel strategy lets you generate consistent premium income on Maze Therapeutics Inc while setting your own entry and exit prices on the underlying. Maze Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own MAZE, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best MAZE wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on MAZE, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable MAZE wheel from a losing one.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of apolipoprotein L1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc.
and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the MAZE wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your MAZE wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Jan 15, 2027 | 20.00 | $0.10 | $2.50 | -0.31 | 116 | 51% | 50.3% | 39.3% | 1 |
| May 21, 2027 | 17.50 | $0.10 | $2.50 | -0.23 | 242 | 51% | 51.0% | 21.5% | 0 |
As of September 21, 2026
Run the Wheel on MAZE With Confidence
Find the best MAZE wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→